相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Sequential Method of Epidermal Growth Factor Receptor Mutation Detection Reduces False Negatives: A New Case With Doublet Mutations of L833V and H835L in China
Yuan Zhuang et al.
CLINICAL LUNG CANCER (2013)
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
Gillian Ellison et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer
Fernando Lopez-Rios et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting
K. Goto et al.
ANNALS OF ONCOLOGY (2012)
EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma
Mai He et al.
CLINICAL CANCER RESEARCH (2012)
Direct Comparison of 3 PCR Methods in Detecting EGFR Mutations in Patients with Advanced Non-Small-Cell Lung Cancer
Takaya Ikeda et al.
CLINICAL LUNG CANCER (2012)
EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: A meta-analysis
Jing-Hua Ren et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2012)
Establishing an EGFR mutation screening service for non-small cell lung cancer - Sample quality criteria and candidate histological predictors
Alexandra F. Leary et al.
EUROPEAN JOURNAL OF CANCER (2012)
A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry
Barbara Angulo et al.
PLOS ONE (2012)
Good Response to Gefitinib in a Lung Adenocarcinoma Harboring a Heterozygous Complex Mutation of L833V and H835L in Epidermal Growth Factor Receptor Gene
Tsung-Ying Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)
Masahiro Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non-Small-Cell Lung Cancer
Qing Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
Vicki Leigh Keedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients
Yi Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Tyrosine Kinase Inhibitors and Epidermal Growth Factor Receptor (EGFR) Mutations in Non-Small Cell Lung Cancer To Test or Not to Test?
Adi F. Gazdar
MEDICINE (2011)
Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers
Jesus Gonzalez-Bosquet et al.
PLOS ONE (2011)
EGFR mutation detection in NSCLC-assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC
Roland Penzel et al.
VIRCHOWS ARCHIV (2011)
ASCO Provisional Clinical Opinion: Epidermal Growth Factor Receptor Mutation Testing in Practice
Mary Beth Beasley et al.
JOURNAL OF ONCOLOGY PRACTICE (2011)
Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas
Zhiyong Liang et al.
BMC CANCER (2010)
Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
Gillian Ellison et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
KRAS Mutation Comparison of Testing Methods and Tissue Sampling Techniques in Colon Cancer
Wilbur A. Franklin et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
Robert Pirker et al.
Journal of Thoracic Oncology (2010)
High-Resolution DNA Melting Analysis: Advancements and Limitations
Carl T. Wittwer
HUMAN MUTATION (2009)
Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis
A. Fassina et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies
Hongdo Do et al.
BMC CANCER (2008)
Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non-small cell lung cancer treated with gefitinib
Toshimi Takano et al.
CLINICAL CANCER RESEARCH (2007)
Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer
Atsushi Horiike et al.
CHEST (2007)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples:: KRAS codon 12 and 13 mutations in non-small cell lung cancer
Michael Krypuy et al.
BMC CANCER (2006)
High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients
Hideharu Kimura et al.
CANCER SCIENCE (2006)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
